This inventor holds 2 USPTO granted patents. Top assignee: Genetics Institute, Inc.. Active years: 2005-2008.
Company Filing History:
Years Active: 2005-2008
Title: Meike Lorenz: Innovator in P-Selectin Glycoprotein Research
Introduction
Meike Lorenz is a prominent inventor based in Arlington, MA (US). She has made significant contributions to the field of molecular biology, particularly in the development of novel binding proteins related to P-selectin glycoprotein ligands. With a total of 2 patents to her name, her work has implications for both diagnostics and therapeutic applications.
Latest Patents
Lorenz's latest patents include the invention of Selectin ligand interactor cytoplasmic (SLIC-1) and a P-selectin glycoprotein ligand (PSGL-1) binding protein. These inventions provide isolated nucleic acid molecules, designated SLIC-1 nucleic acid molecules, which encode novel PSGL-1 binding molecules. Additionally, the patents cover antisense nucleic acid molecules, recombinant expression vectors containing SLIC-1 nucleic acid molecules, and host cells that have been modified with these vectors. The inventions also extend to nonhuman transgenic animals with introduced or disrupted SLIC-1 genes. Furthermore, isolated SLIC-1 proteins, fusion proteins, antigenic peptides, and anti-SLIC-1 antibodies are included in her patents, along with diagnostic methods utilizing these compositions.
Career Highlights
Meike Lorenz is currently associated with Genetics Institute, Inc., where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of P-selectin interactions, which are crucial for various biological processes.
Collaborations
Throughout her career, Lorenz has collaborated with notable colleagues such as Ron Kriz and Gray D Shaw. These partnerships have enhanced her research capabilities and contributed to the success of her innovative projects.
Conclusion
Meike Lorenz stands out as a key figure in the field of molecular biology, with her inventions paving the way for advancements in medical diagnostics and therapeutics. Her contributions continue to impact the scientific community positively.